Funded Tech Companies
Jounce Therapeutics
Operating out of Cambridge, Jounce Therapeutics raised its funding from Pharmstandard, Wellington Management Company and Omega Funds.
Company Overview
Company Name
Jounce Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
780 Memorial Dr.
Cambridge, MA 02138
USA
Cambridge, MA 02138
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Jounce Therapeutics (NASDAQ: JNCE) is focused on the discovery and development of first-in-class cancer immunotherapies designed to work not by treating a patient's tumor directly, but instead by harnessing the patient's immune system to seek out and attack cancerous cells and tumors.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/26/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Murray
Chief Financial Officer
Kim Drapkin
Chief Medical Officer
Elizabeth Trehu
Chief Technical Officer
Stephen Farrand
VP - Bus. Development
Hugh Cole
VP - Human Resources
Ted Harding
VP - Regulatory Affairs
Allison Nance
Company Investors
- Pharmstandard
- Wellington Management Company
- Omega Funds
- Nextech Invest
- Foresite Capital
- Casdin Capital
- Cormorant Asset Management
- Redmile Group (Michael Lee)
- Third Rock Ventures (Cary Pfeffer)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs